N@N

Debjit Chattopadhyay Maintained (BOLD) at Strong Buy with Decreased Target to $33 on, Oct 12th, 2018

^{Published on 2024-10-26 09:27:47 - WOPRAI, Debjit Chattopadhyay}
 

Debjit Chattopadhyay of HC Wainwright & Co., Maintained "Boundless Bio, Inc." (BOLD) at Strong Buy with Decreased Target from $40 to $33 on, Oct 12th, 2018.

Debjit has made no other calls on BOLD in the last 4 months.

There are 3 other peers that have a rating on BOLD. Out of the 3 peers that are also analyzing BOLD, 1 agrees with Debjit's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Mohit Bansal of "Citigroup" Initiated at Hold and Held Target at $40 on, Tuesday, August 21st, 2018

These are the ratings of the 2 analyists that currently disagree with Debjit

---

• David Nierengarten of "Wedbush" Maintained at Buy with Increased Target to $52 on, Monday, October 8th, 2018
• Difei Yang of "Mizuho" Upgraded from Hold to Strong Buy on, Wednesday, August 8th, 2018

Contributing Sources

---